Anthem Stock Forecast for 2022 - 2025 - 2030
Updated on 05/19/2022
Anthem's stock price reaches the average target of $575.00 by 2023 as expected recently by eight notable experts, there would be a potential upside of approximately 20.7% from the last closing price in May, 2022. This possible increase is based on a high estimate of $642.00 and a low estimate of $335.00. If you are not interested in ANTM stock, you may be interested in its competitors.
20.7% Upside

Anthem Price Forecast for 2022 - 2025 - 2030
In the past three years, Anthem's Price has significantly grown, increasing from $264.41 to $432.31 – a growth of 63.5%. The next year looks very promising for Anthem, with analysts predicting Price of $476.40 – an increase of 10.2%. Over the next nine years, experts anticipate that ANTM's Price will grow at a rate of 145.77%.
Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts |
---|---|---|---|---|---|---|---|
BRK.A Stock Forecast | Berkshire Hathaway | Outperform |
5
|
$461.00k | $556.70k | 21.48% | 1 |
UNH Stock Forecast | UnitedHealth Group | Outperform |
7
|
$471.38 | $526.47 | 25.48% | 6 |
WMT Stock Forecast | Walmart | Outperform |
6
|
$122.43 | $168.96 | 31.5% | 17 |
ALV Stock Forecast | Allianz | Outperform |
6
|
200.85€ | 249.88€ | 24.47% | 5 |
CI Stock Forecast | Cigna | Outperform |
7
|
$257.57 | $259.08 | 14.53% | 6 |
Anthem Revenue Forecast for 2022 - 2025 - 2030
In the past three years, Anthem's Revenue has significantly grown, increasing from $92091.00 to $138643.00 – a growth of 50.55%. The next year looks very promising for Anthem, with analysts predicting Revenue of $153374.40 – an increase of 10.63%. Over the next nine years, experts anticipate that ANTM's Revenue will grow at a rate of 102.23%.
Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts |
---|---|---|---|---|---|---|---|
CS Stock Forecast | AXA | Outperform |
7
|
23.42€ | 26.51€ | 29.38% | 11 |
HUM Stock Forecast | Humana | Outperform |
6
|
$420.04 | $480.18 | 19.04% | 11 |
CNC Stock Forecast | Centene | Outperform |
8
|
$81.77 | $92.50 | 17.4% | 6 |
Anthem Dividend per Share Forecast for 2022 - 2025 - 2030
In the last three years, Anthem's DPS has grown by 50.67%, from $3.00 to $4.52. For the next year, analysts are expecting DPS to reach an unimpressive $4.96 – an increase of 9.73%. Over the next nine years, experts predict that DPS will grow by 154.2%.
Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts |
---|---|---|---|---|---|---|---|
AIG Stock Forecast | American International Group | Outperform |
7
|
$58.30 | $65.43 | 18.35% | 11 |
AFL Stock Forecast | Aflac | Hold |
8
|
$56.32 | $62.77 | 10.09% | 6 |
MUV2 Stock Forecast | Münchener Rückversicherungs-... | Outperform |
5
|
225.50€ | 276.04€ | 21.95% | 10 |
Anthem Free Cash Flow Forecast for 2022 - 2025 - 2030
In the last three years, Anthem's Free Cash Flow has grown by 177.85%, rising from $2619.00 to $7277.00. In the following year, the 3.00 analysts surveyed believe that ANTM's Free Cash Flow will decrease by 15.21%, reaching a dismal $10845.00. Over the next nine years, experts predict that Anthem's Free Cash Flow will grow at a rate of 49.03%.
Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts |
---|---|---|---|---|---|---|---|
G Stock Forecast | Assicurazioni Generali S.p.A. | Outperform |
5
|
18.00€ | 17.63€ | 11.11% | 8 |
MOH Stock Forecast | Molina Healthcare | Outperform |
0
|
$304.00 | $282.69 | 13.49% | 2 |
CAH Stock Forecast | Cardinal Health | Hold |
5
|
$55.68 | $57.23 | 0.57% | 4 |
Anthem Net Income Forecast for 2022 - 2025 - 2030
In the past three years, Anthem's Net Income has seen a tremendous increase, going from $3750.00 to $6104.00 – an increase of 62.77%. Next year, analysts are expecting Net Income to reach $6944.00 – an increase of 13.76%. Over the next nine years, the forecast is for Net Income to grow by 95.17%.
Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts |
---|---|---|---|---|---|---|---|
AV. Stock Forecast | Aviva | Outperform |
3
|
£4.14 | £4.70 | 43% | 7 |
DVA Stock Forecast | DaVita | Hold |
6
|
$94.56 | $124.50 | 21.09% | 2 |
UHS Stock Forecast | Universal Health Services | Hold |
8
|
$119.08 | $147.80 | 11.69% | 7 |
Anthem EBITDA Forecast for 2022 - 2025 - 2030
In the last three years, Anthem's EBITDA has grown by 53.61%, rising from $6363.00 to $9774.00. For next year, analysts predict earnings per share of $11164.57, which would mean an increase of 14.23%. Over the next nine years, experts predict that Anthem's EBITDA will grow at a rate of 81.55%.
Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts |
---|---|---|---|---|---|---|---|
THC Stock Forecast | Tenet Healthcare | Outperform |
4
|
$66.73 | $82.53 | 55.85% | 7 |
INOV Stock Forecast | Inovalon Holdings | - |
1
|
$41.06 | $41.00 | -100% | 5 |
7181 Stock Forecast | Japan Post Insurance | Outperform |
5
|
¥1.80k | ¥0.00 | 22.49% | 0 |
Anthem EBIT Forecast for 2022 - 2025 - 2030
In the past three years, Anthem's EBIT has seen significant growth, rising from $5818.00 to $8957.00 – a growth of 53.95%. In the next year, analysts believe that EBIT will reach a reasonable $9927.08 – an increase of 10.83%. For the next nine years, the forecast is for EBIT to grow by 131.82%.
Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts |
---|---|---|---|---|---|---|---|
GTS Stock Forecast | Triple-S Management | - |
0
|
$35.53 | $19.00 | -100% | 0 |
NasdaqGS:MGLN Stock Forecast | Magellan Health | - |
2
|
$0.00 | $95.00 | 0% | 0 |
Anthem EPS Price Prediction Forecast for 2022 - 2025 - 2030
In the past three years, Anthem's EPS has significantly grown, increasing from $15.89 to $25.98 – a growth of 63.5%. The next year looks very promising for Anthem, with analysts predicting EPS of $28.63 – an increase of 10.2%. Over the next nine years, experts anticipate that ANTM's EPS will grow at a rate of 145.77%.
Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts |
---|